MAIA Biotechnology, Inc. (NYSEAM: MAIA)
Health Care · Biotechnology · US
$1.11
-2.63% today · +12.2% 1Y
MAIA Biotechnology, Inc. (NYSEAM: MAIA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $68.54M and employs 13 people.
Over the last twelve months the share price has gained 12.2%, trading between 0.89 and 3.19.
Tweenvest scores MAIA Biotechnology, Inc. across four factors: quality 42/100, value 39/100. Its strongest factor is quality.
MAIA price history
Key figures
- Market cap
- $68.54M
- Revenue (TTM)
- —
- P/E
- -2.73
- EPS
- -0.49
- Dividend yield
- —
- Beta (5Y)
- 0.30
- 52-week high
- $3.19
- 52-week low
- $0.89
- Avg volume (3M)
- —
- Shares outstanding
- 61.75M
- Employees
- 13
- Next earnings
- —
About MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc. is a clinical-stage biotech firm dedicated to discovering, developing, and commercializing treatments for various cancers, with a primary focus on non-small cell lung cancer. The company's leading experimental compound, THIO, is an investigational drug candidate that utilizes a unique dual mechanism by targeting telomeres and stimulating an immune response. Established in 2018, the enterprise maintains its headquarters in Chicago, Illinois.
- ISIN
- US5526411021
- Founded
- 2018
- Listed since
- Jul 28, 2022
- Exchange
- NYSE American LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Coya Therapeutics, Inc.NasdaqCM: COYA | $70.84M | $3.02 | +0.67% |
| BIOTON S.A.WSE: BIO | $70.64M | zł3.34 | -2.20% |
| Cell Biotech Co., Ltd.KOSDAQ: A049960 | $69.69M | ₩13,660.00 | -0.87% |
| Corbus Pharmaceuticals Holdings, Inc.NasdaqCM: CRBP | $69.55M | $3.38 | -0.44% |
| BioPorto A/SCPSE: BIOPOR | $68.38M | Dkr0.94 | -1.05% |
| Great Novel Therapeutics Biotech & MedicalsTPEX: 7427 | $68.34M | NT$52.50 | -4.72% |
| BIONET Therapeutics Corp.TPEX: 7808 | $68.06M | NT$32.00 | -4.90% |
| Artgen Biotech PJSCMISX: ISKJ | $68.01M | RUB59.54 | +1.43% |